NOI to Sole Source Custom mRNA Synthesists
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 68HE0B25Q0074
- Agency
-
Office of Research and Development
Headquarters Offices, Environmental Protection Agency
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The Environmental Protection Agency's Office of Research and Development is seeking to sole source a contract for custom mRNA synthesis services within the Testing Laboratories and Services (NAICS 541380) category. The pre-solicitation notice indicates the agency intends to procure specialized reference laboratory testing capabilities focused on mRNA synthesis. This opportunity, posted on March 21, 2025, has a response deadline of March 31, 2025, suggesting a relatively tight timeline for potential vendors. The contract will be evaluated based on the vendor's capability to provide high-quality, precise mRNA synthesis services that meet the agency's specific research requirements. Key qualifications will likely include technical expertise in molecular biology, demonstrated experience with custom mRNA production, and the ability to meet stringent scientific research standards.
This pre-solicitation notice does not indicate a specific set-aside designation, suggesting the opportunity is open to a broad range of potential contractors. While the exact award value is not specified in the notice, the specialized nature of custom mRNA synthesis suggests this could be a high-value technical services contract. The procurement appears to be for a specific research project within the EPA's Office of Research and Development, potentially involving advanced scientific research applications. The Reference Laboratory Testing (PSC Q301) classification implies complex, precision-driven laboratory work requiring significant technical capabilities. The sole source approach suggests the agency has identified a specific vendor with unique capabilities that cannot be easily replicated by other potential contractors in the marketplace.
Notice text
Notice of Intent to Sole Source Custom mRNA Synthesis
Notice history
| Notice | Type | Posted |
|---|---|---|
| Custom mRNA Standard | Award Notice | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| Single Purchase of an Agilent 8890 GC System Custom with dual ECD detectors | EPA Region 4 | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity